Regulatory Issues

Featured Article

A Deeper Look Into the Flu Vaccine and Its Importance to Public Health

A Deeper Look Into the Flu Vaccine and Its Importance to Public Health

If flu vaccines were mandatory for all school-age children, the savings on direct healthcare costs alone would easily reach into the tens of millions.

Latest

Opioid-Induced Constipation Treatments Receive Updated Labels

Opioid-Induced Constipation Treatments Receive Updated Labels

The prescribing information for several medications has been updated to provide clarification of the opioid-induced constipation indication.

FDA's Flush List: Assessing the Environmental Impact

FDA's Flush List: Assessing the Environmental Impact

Researchers attempted to quantify the environmental effects of disposing certain drugs by flushing them down the toilet, and found that this approach poses a negligible eco-toxicological risk.

Meningitis Vaccine: Precautionary Recall

Meningitis Vaccine: Precautionary Recall

A precautionary recall of Menveo, a meningitis vaccine, was announced by GlaxoSmithKline due to a mechanical intervention.

UN Calls on Polities to Help End Discrimination in Healthcare

UN Calls on Polities to Help End Discrimination in Healthcare

Widespread discrimination in healthcare has taken many forms, and violates the most fundamental of human rights. WHO established a goal "to ensure that none is left behind and to read the furthest behind first."

Pharmacy-Driven Model of Primary Care Preferred by Patients

Pharmacy-Driven Model of Primary Care Preferred by Patients

Patients express preference for a pharmacy-driven model of primary care vs a pharmacy offering primary care services.

Ceftin Oral Suspension to be Discontinued

Ceftin Oral Suspension to be Discontinued

GlaxoSmithKline has made the decision to discontinue manufacturing Ceftin Oral Suspension, a cephalosporin antibacterial drug.

WHO Updates, Revises Essential Medicines List

WHO Updates, Revises Essential Medicines List

WHO has updated its Essential Medicines List to include new recommendations on which antibiotics to use for common infections and serious conditions.

FDA Policy Seeks to Increase Number of Generics on Market

FDA Policy Seeks to Increase Number of Generics on Market

The FDA has announced a new policy to expedite reviews of generic drug applications in cases where competition is limited.

AMA Endeavors to Increase Transparency of Rx Pricing

AMA Endeavors to Increase Transparency of Rx Pricing

The American Medical Association is calling for more transparency in drug pricing amid rising costs that are putting some lifesaving medications out of reach for patients and communities.

FDA to Remove Pain Drug from the Market

FDA to Remove Pain Drug from the Market

The FDA has requested the removal of reformulated Opana ER (oxymorphone HCl; Endo) from the market.